Education

Diploma
of Higher Education (Magister in Pharmacy) with Highest Honours from
National Pharmaceutical University, Ukraine. 1995. Specialty:
Pharmacy. Post-graduate education (National Pharmaceutical University): Pedagogic and psychology (1997)
Post-graduate education (Kharkiv Postgraduate Medical Academy):
Bacteriology  (1999)
Post-graduate education (Kharkiv Postgraduate Medical Academy): Clinical immunology and allergology (2002)
Post-graduate education (National Pharmaceutical Institute): GMP in biotechnology of vaccines (2014)
Post-graduate education (National Pharmaceutical Institute): GMP in biotechnology  of immune-biological drugs(2014)

Education and training 

Ph.D. in pharmacy (drugs technology) from National pharmaceutical university,
Kharkiv, Ukraine. 1996. Thesis title: Ground of synthesis of targeting
anticancer and antiviral drugs.
Sc.D. (Dr.Hab.) in pharmacy (pharmaceutical chemistry and pharmacognosy) from P.L.Shupik national medical academy of postgraduate education, Kyiv, Ukraine, 2004. Thesis title: Development of drugs from natural and chemically modified biopolymers (peptides, polynucleotide, tannins,
polysaccharides).
Senior scientist in pharmacy (pharmaceutical chemistry and pharmacognosy), Kyiv, High Attestation Commission of Ukraine.
Senior scientist in immunology and allergology, Kyiv, High Attestation Commission of Ukraine.
Professor in pharmaceutical chemistry and pharmacognosy, Ministry of science and education, 2015
University degree: Diploma of Higher Education (Magister in Pharmacy)
with Highest Honours from National Pharmaceutical University, Ukraine.
1995. Specialty: Pharmacy.

Current positions

Head of the laboratory and clinical department of molecular
immunopharmacology, Mechnicov institute of microbiology and immunology, Kharkiv, Ukraine
•    Secretary-Editor of Journal “Annals of Mechnicov Institute”
•    Professor of National pharmaceutical university
(Institute of postgraduate education) , DPT. of  drug technology
and clinical pharmacy
Executive Vice President, research & development of Noigel.

Professional awards, grants, fellowships 

 Awards of  “Marquis Who is Who in medicine in the world” since 2006
•    Awards of  “Marquis Who is Who in science and Engineering in the world” since 2007
•    Stipendium of the cabinet of the Ministry of Ukraine for young scientists (1999)
•    State premium of President of Ukraine for the young scientist (2007)
•    8 State Ukrainian Grants since 1999

Memberships

International society of microbiologists
Membership in Research board of American
biographical institute (since 2006)

Publications

More than 124 articles in scientific journals, 74 patents and applications (incl. 5 USA patents), one monography

Farber, B.S., Martynov, A.V., & Kleyn, I.R. (2018). CREATION OF NEW MEDICAL DRUGS BASED ON TRIZ AND COMPUTER MATHEMATICAL MODELING. Annals of Mechnikov Institute, (4), 15–34. http://doi.org/10.5281/zenodo.2547580

Martynov, A., Didenko, G., Farber, B., Farber, S., & Cruts, O. (2017). The anticancer activity and immune-modulating properties of combinatorial ensemble complementary (antisense) microRNA (fRNA) in combination with the immunomodulator-glycoprotein lectin from B. subtilis B-7025. BioRxiv, 151829.

Martynov A., Didenko G., Farber B., Farber S., Cruts, O. The anticancer activity of antisense micro RNA (fRNA) in combination with the lectin from Bacillus subtilis B‐7025. Journal of Pharmacy and Pharmacology, 2018. DOI: 10.1111/jphp.12898 3. Martynov, A. V., & Smelyanskaya, M. V. (2005). Antiproliferative Properties of Chemically Modified Recombinant IFN-α2b. Journal of interferon & cytokine research, 25(7), 414-417.

Martynov, A. V., Farber, B. S., Farber, S. B., & Kabluchko, T. V. (2015). Synthesis of the ensembles from succinylated interleukin-2 derivatives and their biological activity in vitro. ScienceRise, (11 (4)), 25-30.

A method useable in clinics for significantly increasing the effectiveness of treating patients with malignant tumors Arthur Martynov, Boris Farber, Sonya Sophya Abstracts from Athens, Greece 10th Congress of the European Federation of Internal Medicine October 5–8, 2011.// European Journal of Internal Medicine, Suppl. 1 (2011), Vol. 22. S29

The use of antiviral drugs for the treatment of cancer patients Arthur Martynov, Boris Farber, Sonya Sophya Abstracts of the XXX Congress of the European Academy of Allergy and Clinical Immunology, Istanbul, Turkey 11-15 June 2011. // Allergy 66, Suppl. 94 (2011): 658-727

A new anti-viral drug with a quick, direct effect Arthur Martynov, Boris Farber, Sonya Sophya. 2011 FIP Congress in Hyderabad (India), Pharmaceutical Biotechnology Posters on Monday, 5 September 2011,

T.110. A new anti-cancer drug overcomes cancer resistance t.111. Quasi-life antiviral drug with a quick, direct effect, a wide spectrum of activity / FOCIS 2011, Abstract Supplement, June 23 – 26 • Washington, D.C., P.123 (www.focisnet.org)

Martynov, A.V, Batrak, E.A, & Kabluchko, T.V. (2016). HPLC for control stability of quercetin injectable dosage. Annals of Mechnikov Institute, (4), 53–57. http://doi.org/10.5281/zenodo.192301

Martynov AV, Bomko TV, Nosalskaya TN, Lisnyak Yu.V, Romanova EA, Kabluchko TV, Farber BS, Farber SB. (2016). Tuberculosis is an infectious pathology of the immune system. Annals of Mechnikov Institute, (3), 8–14. http://doi.org/10.5281/zenodo.167423

Lisnyak Yu. V, & Martynov AV. (2016). Structural organization of bacterial ureases. Annals of Mechnikov Institute, (3), 22–30. http://doi.org/10.5281/zenodo.167426

Pohorila MS, Martynov AV, Romanova OA, Sidorenko TA, Igumnova NI, Yukhimenko VI, & Shcherbak OM. (2016). New formyl-peptides, as stimulators of non-specific organism resistance against mycobacteria. Annals of Mechnikov Institute, (3), 49–52. http://doi.org/10.5281/zenodo.167430

Upir D.V., Kislychenko VS, Ilyinskaya N.I., Martynov A.V. Standardization of gathering for the treatment of the lung infectious diseases and tuberculosis // Bulletin of pharmacy .- 2013.- T. 2B № 74, C.38-40)

Romanova O.A., Martynov AV, Pogorila MS, Shcherbak O.M.,. Sidorenko T.A Igumnova N.I., Yukhimenko VI. Effect of experimental compositions from formyl peptides on the functional capacity of lymphocytes in vivo and in vitro / // Abstracts of the report to the international scientific and practical conference Innovate technology in medicine: experience of Poland and Ukraine. April 28-29, 2017 – Lublin. The Republic of Poland – p. 170-172)

Influence Of Non-Metabolic Microbial Growth Promotors (AMP Activators) On The Sensitivity To Antimicrobials In The Multiresistant Microbial Strains Artur Martynov, Tatyana Osolodchenko, Boris Farber, Sophya Farber bioRxiv 143438; DOI: https://doi.org/10.1101/143438

Martynov, AV, Chuprinova, SI, Osolodchenko, T. P., Batrak, O. A., Zavada, N. P., Ryabova, I. S., & Sticker, L. G. (2008). Effect of the combined action of chemical origin stimulants on the growth rate of the microbial mass of Pseudomonas aeruginosa. AMI, (3), 20-24. http://www.imiamn.org.ua/journal/3_2008/PDF/7.pdf

Influence of Microbial Growth Enhancers on Antibiotic Resistance of Polyresistance Microorganisms Strains/ SMi’s Superbugs & Superdrugs, New Jersey, USA. 14-16 NOV 2016/ Farber B., Kleyn I., Martynov A.

The novel strategy to fight multidrug resistance by multiple drugs synergism, based on docking in drug design and TRIZ/ SMi’s Superbugs & Superdrugs, New Jersey, USA. 14-16 NOV 2016/ Farber B., Kleyn I., Martynov A. http://www.globaleventslist.elsevier.com/events/2016/03/superbugs-superdrugs/

The novel strategy to fight multidrug resistance by multiple drugs synergism, based on docking in drug design AND TRIZ. Change of paradigm/ Synopsis investors conference, New York, 15 DEC, 2016/Ph.D., Sc.D. Boris Farber, Dr.Ilya Kleyn, Dr.Artur Martynov, Tatyana Osolodchenko, Ph.D., Dr. Tatyana Kabluchko, Yury Lisnyak, Ph.D., Tatyana Bomko, Ph.D.,Tatyana Nosalskaya, Ph.D., Helen Romanova, Ph.D., Helen Grishina, Ph.D.

Lisnyak, Y. V., Martynov, A. V., Baumer, V. N., Shishkin, O. V., & Gubskaya, A. V. (2007). Crystal and molecular structure of β-cyclodextrin inclusion complex with succinic acid. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 58(3-4), 367-375.